Business Context and Reporting Period
This Form 8-K is filed by Fluidigm Corporation (not Standard BioTools Inc.) on January 12, 2016. The report discloses the issuance of a press release announcing preliminary financial results for the fourth quarter and full year 2015.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) containing preliminary revenue figures for Q4 and full-year 2015. However, the specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity are not provided within the body of this 8-K document.
Material Changes
The filing does not contain specific comparative data or a discussion of material changes versus prior periods. It serves solely as a notification that preliminary results have been announced.
Guidance, Outlook, and Risks
The document does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific revenue figures for Q4 and full-year 2015 by reviewing Exhibit 99.1 (the press release) referenced in this filing.
- Confirm the company name is Fluidigm Corporation, as the metadata provided in the request listed "Standard BioTools Inc."
- Check for subsequent filings (e.g., 10-K) to obtain audited financial statements and detailed management discussion.